Dual FGF-21/GLP-1 Agonist (Alteogen/Lynkogen)

N/A

Report date: 2025/01/26 18:15:50

Base Information

Drug NameDual FGF-21/GLP-1 Agonist (Alteogen/Lynkogen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonistsFibroblast growth factor receptors agonistsKlotho beta agonists
TargetsGlucagon-like peptide 1 receptorKlotho betaFibroblast growth factor receptors
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlteogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesLynkogen IncAlteogen Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A